Significant Contract Modifications ($10M+) — July 03, 2026

This 10-year, firm fixed-price delivery order provides a predictable $90M annual revenue stream for the small business, directly supporting domestic high-assay low-enriched uranium production. The contract's alignment with U.S. goals to reduce reliance on foreign nuclear fuel suppliers creates a durable growth catalyst.

The $3.52B obligation to RAPID DEPLOYMENT INC from HHS is the single largest contract in this period, representing 60% of total digest value. While details are sparse, the sheer size signals a major federal commitment to this recipient, warranting close monitoring for revenue recognition and follow-on awards.

The competitive award for a high-containment laboratory at CDC indicates continued federal prioritization of biodefense and infectious disease research infrastructure. This could catalyze follow-on contracts for similar facilities, benefiting construction and engineering firms with federal lab expertise.

KBR's $386.4M cost-plus-fixed-fee contract with NASA Ames has only $186.6M outlaid and ends in November 2024. With limited remaining runway, failure to secure a follow-on award would create a revenue gap for KBR's government services segment.

MANHATTAN TORCON A JOINT VENTURE faces high execution risk on the $491.8M firm-fixed-price CDC lab construction contract. Fixed-price terms on a complex, long-duration (3.9 years) project could lead to cost overruns, especially if scope changes occur.

AMERICAN CENTRIFUGE OPERATING, a small business, must manage firm fixed-price execution risk on a $90M annual contract for HALEU production. Any cost overruns or production delays could strain the company's financial capacity.

The $3.52B RAPID DEPLOYMENT INC contract from HHS lacks pricing and competition details, creating budget risk. If the contract is cost-plus or subject to continuing resolution uncertainty, future obligations could be delayed or reduced.

The digest shows no single recipient winning multiple awards, but 60% of total value is concentrated in one contract (RAPID DEPLOYMENT INC). This concentration risk means any disruption to that award materially impacts the digest's aggregate value.

AMERICAN CENTRIFUGE OPERATING's $900M HALEU contract provides a 10-year, $90M annual revenue stream with potential for follow-on awards as the U.S. expands domestic nuclear fuel production. Investors should watch for option exercises or additional DOE HALEU solicitations.

The CDC's $491.8M high-containment lab contract signals sustained federal investment in biodefense infrastructure. Companies with expertise in federal lab construction (e.g., MANHATTAN TORCON joint venture partners) could benefit from follow-on projects at CDC or other HHS agencies.

Raytheon's $606.7M sole-source contract for NOAA's JPSS Common Ground System indicates a strong incumbent position. As the contract nears its end (2024), Raytheon could secure a sole-source extension or recompete advantage, providing stable revenue for RTX Corp.

The $900M DOE contract to AMERICAN CENTRIFUGE OPERATING for HALEU production underscores a multi-year federal push to reduce reliance on foreign uranium suppliers. This is the only contract in the digest explicitly tied to energy security policy.

Two contracts totaling $856.4M (CDC lab construction and NOAA ground system) highlight civilian agency spending on physical and IT infrastructure. These are non-defense, reducing exposure to DOD budget volatility.

KBR's $386.4M NASA Ames contract ending in November 2024 highlights the renewal risk for long-term NASA support contracts. This could create opportunities for competitors or extensions for incumbents.

{"entity"=>"AMERICAN CENTRIFUGE OPERATING, LLC", "reason"=>"10-year HALEU contract provides long-term revenue visibility; execution risk on fixed-price terms", "trigger"=>"DOE performance milestone announcements, option exercises, financial disclosures"}

{"entity"=>"KBR, Inc.", "reason"=>"NASA Ames contract expires November 2024; renewal risk for $364.7M obligated value", "trigger"=>"NASA follow-on award or recompete announcement"}

{"entity"=>"RAYTHEON COMPANY (RTX Corp)", "reason"=>"NOAA sole-source contract nearing end; potential extension or recompete", "trigger"=>"NOAA option exercise or extension decision before Oct 2023"}

{"entity"=>"MANHATTAN TORCON A JOINT VENTURE", "reason"=>"High execution risk on $491.8M fixed-price CDC lab construction", "trigger"=>"Contract modifications, change orders, progress reports"}